Literature DB >> 1905359

In vivo interaction of Escherichia coli lac repressor N-terminal fragments with the lac operator.

A M Khoury1, H S Nick, P Lu.   

Abstract

Escherichia coli lac repressor is a tetrameric protein composed of 360 amino acid subunits. Considerable attention has focused on its N-terminal region which is isolated by cleavage with proteases yielding N-terminal fragments of 51 to 59 amino acid residues. Because these short peptide fragments bind operator DNA, they have been extensively examined in nuclear magnetic resonance structural studies. Longer N-terminal peptide fragments that bind DNA cannot be obtained enzymatically. To extend structural studies and simultaneously verify proper folding in vivo, the DNA sequence encoding longer N-terminal fragments were cloned into a vector system with the coliphage T7 RNA polymerase/promoter. In addition to the wild-type lacI gene sequence, single amino acid substitutions were generated at positions 3 (Pro3----Tyr) and 61 (Ser61----Leu) as well as the double substitution in a 64 amino acid N-terminal fragment. These mutations were chosen because they increase the DNA binding affinity of the intact lac repressor by a factor of 10(2) to 10(4). The expression of these lac repressor fragments in the cell was verified by radioimmunoassays. Both wild-type and mutant lac repressor N termini bound operator DNA as judged by reduced beta-galactosidase synthesis and methylation protection in vivo. These observations also resolve a contradiction in the literature as to the location of the operator-specific, inducer-dependent DNA binding domain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905359     DOI: 10.1016/0022-2836(91)90659-t

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Plasticity of quaternary structure: twenty-two ways to form a LacI dimer.

Authors:  L Swint-Kruse; C R Elam; J W Lin; D R Wycuff; K Shive Matthews
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

2.  Fine-tuning function: correlation of hinge domain interactions with functional distinctions between LacI and PurR.

Authors:  Liskin Swint-Kruse; Christopher Larson; B Montgomery Pettitt; Kathleen Shive Matthews
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

3.  Contacts between Bacillus subtilis catabolite regulatory protein CcpA and amyO target site.

Authors:  J H Kim; G H Chambliss
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  Comparison of simulated and experimentally determined dynamics for a variant of the Lacl DNA-binding domain, Nlac-P.

Authors:  L Swint-Kruse; K S Matthews; P E Smith; B M Pettitt
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

5.  Modified nucleotides reveal the indirect role of the central base pairs in stabilizing the lac repressor-operator complex.

Authors:  X Zhang; P A Gottlieb
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

6.  Role of the purine repressor hinge sequence in repressor function.

Authors:  K Y Choi; H Zalkin
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

Review 7.  Functions of the gene products of Escherichia coli.

Authors:  M Riley
Journal:  Microbiol Rev       Date:  1993-12

8.  Transcriptional enhancer related DNA sequences: anomalous 1H NMR NOE crosspeaks.

Authors:  M E Donlan; P Lu
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

9.  The lac repressor hinge helix in context: The effect of the DNA binding domain and symmetry.

Authors:  Danielle Seckfort; Gillian C Lynch; B Montgomery Pettitt
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-01-17       Impact factor: 3.770

10.  Data on publications, structural analyses, and queries used to build and utilize the AlloRep database.

Authors:  Filipa L Sousa; Daniel J Parente; Jacob A Hessman; Allen Chazelle; Sarah A Teichmann; Liskin Swint-Kruse
Journal:  Data Brief       Date:  2016-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.